Ethyl 7-bromo-4-chloroquinoline-3-carboxylate, 95.0%, 5g

2-(5-Bromopyridin-3-yl)-2-methylpropanenitrile, 1g

Oxalic acid solution, ROTI®Volum 0.05 mol/l - 0.1 N, ampoule, 1 piece, plastic packaging.

3-(Morpholine-4-sulfonyl)-aniline, 95.0%, 250mg

5-(1-METHYLCYCLOPROPOXY)-1H-INDAZOLE, 95%, 1g

N1,N6-Dimethylhexane-1,6-diamine, 98.0%, 1g

4-(4-Fluorophenyl)pyridine-2-carboxylic acid, 97.0%, 250mg

Urea, N-[2-chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenyl]-N'-propyl-, 98%, 5mg

3-Bromo-2-fluoro-6-methyl-benzoic acid, 97%, 100mg

ETHYL 3-PHENYL-2-(PIPERIDIN-1-YL)PROPANOATE, 95.0%, 1g

3-Chloroisoquinolin-5-boronic acid, 97%, 100mg

N-Methyl-3-(methylamino)propanamide, 95.0%, 1g

2-Phenyl-2,6-diazaspiro[3.3]heptan-1-one, 95.0%, 50mg